Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06995755 · ClinicalTrials.gov registry record · NA
Atlas:Text Messaging Program With Weather Alerts, Local Resources & Insights for Addressing Climate Change
A NA study, sponsored by Pro-Change Behavior Systems.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT06995755: Completed NA study, sponsored by Pro-Change Behavior Systems.
NCT06995755 is a NA study that has completed, run by Pro-Change Behavior Systems. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06995755, a NA study, has completed, sponsored by Pro-Change Behavior Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
Climate change is an urgent public health threat, and climate-related health risks disproportionately impact vulnerable populations. To date, digital climate change communications have been limited to one-directional, one size-fits all messaging based on a single theoretical approach (i.e., framing). This Phase I SBIR explored the acceptability and effects of an innovative solution: atlas - an interactive text messaging program that leverages insights from behavior change science and integrates data from the National Weather Service to engage a broad spectrum of users with varying levels of concern about climate change and tailor the user experience. atlas 1) provided information on current climate-related and environmental risks (e.g., high temperatures, air quality alerts, asthma triggers etc.) that might adversely affect a user's current health conditions; 2) linked users to local zip-code matched resources to mitigate their specific risk (e.g., cooling centers, hurricane shelters); 3) implemented a full range of best practices in tailored health behavior change communications to personalize ongoing communications regarding the link between human actions and extreme weather based on the user's level of concern about and belief in climate change; and 4) provided customized actionable tips for addressing climate change to promote climate efficacy at the individual, community, and policy/advocacy level based on the user's level of motivation. Developed in collaboration with community members, 2 community health experts, and 4 climate change experts, atlas achieved sustained engagement and impact by hyper-personalizing the user experience and seamlessly integrating actionable insights from multiple theories of behavior change and communication frameworks. Extensive end user and expert input ensured atlas was designed for rapid dissemination. Residents of a city in a New England state (n=54) were recruited to participate in a 30-day pilot test. The primary outcome,
Primary Outcome
A 3-item measure of response efficacy that assessed individual, community, and governmental/policy level efficacy for mitigating climate change. It is measured using a Likert scale, with total scores ranging from 3 to 15. Higher scores reflect a better outcome.
Interventions
- BEHAVIORAL atlas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2024-06-25 |
| Est. Completion | 2024-08-21 |
| Phase | NA |
What the finished NCT06995755 record still lists
NCT06995755 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which atlas is the first listed.
NCT06995755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06995755 about?
NCT06995755 is a clinical study titled "Atlas:Text Messaging Program With Weather Alerts, Local Resources & Insights for Addressing Climate Change". Climate change is an urgent public health threat, and climate-related health risks disproportionately impact vulnerable populations. To date, digital climate change communications have been limited to one-directional, one size-fits all messaging based on a single theoretical approach (i.e., framing)...
What is the current status of trial NCT06995755?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2024-06-25. Estimated completion is 2024-08-21.
What interventions are being tested in trial NCT06995755?
The interventions under investigation include: atlas (BEHAVIORAL).
Who is sponsoring clinical trial NCT06995755?
This trial is sponsored by Pro-Change Behavior Systems, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06995755's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI